These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30488333)

  • 21. A cost-effectiveness analysis of a proposed national falls prevention program.
    Wu S; Keeler EB; Rubenstein LZ; Maglione MA; Shekelle PG
    Clin Geriatr Med; 2010 Nov; 26(4):751-66. PubMed ID: 20934620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An economic framework for preventive care advice.
    Pauly MV; Sloan FA; Sullivan SD
    Health Aff (Millwood); 2014 Nov; 33(11):2034-40. PubMed ID: 25368000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applying cost analysis methods to school-based prevention programs.
    Chatterji P; Caffray CM; Jones AS; Lillie-Blanton M; Werthamer L
    Prev Sci; 2001 Mar; 2(1):45-55. PubMed ID: 11519374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.
    Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S;
    Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluation of osteoporosis prevention.
    Johannesson M; Jönsson B
    Health Policy; 1993 May; 24(2):103-24. PubMed ID: 10126753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valuing Our Communities: Ethical Considerations for Economic Evaluation of Community-Based Prevention.
    Crowley M; Jones D
    Am J Community Psychol; 2017 Dec; 60(3-4):309-315. PubMed ID: 29154476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness.
    Luong Nguyen LB; Yazdanpanah Y; Maman D; Wanjala S; Vandenbulcke A; Price J; Parker RA; Hennequin W; Mendiharat P; Freedberg KA
    Clin Infect Dis; 2018 Aug; 67(5):719-726. PubMed ID: 29746619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.
    Adi Y; Juarez-Garcia A; Wang D; Jowett S; Frew E; Day E; Bayliss S; Roberts T; Burls A
    Health Technol Assess; 2007 Feb; 11(6):iii-iv, 1-85. PubMed ID: 17280624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-Effectiveness of Disease Management Programs for Cardiovascular Risk and COPD in The Netherlands.
    Tsiachristas A; Burgers L; Rutten-van Mölken MP
    Value Health; 2015 Dec; 18(8):977-86. PubMed ID: 26686781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic evaluation of the NET intervention versus guideline dissemination for management of mild head injury in hospital emergency departments.
    Mortimer D; Bosch M; Mckenzie JE; Turner S; Chau M; Ponsford JL; Knott JC; Gruen RL; Green SE
    Implement Sci; 2018 Dec; 13(1):147. PubMed ID: 30518430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cost-effectiveness of HIV prevention from a managed care perspective.
    Pinkerton SD; Holtgrave DR
    J Public Health Manag Pract; 1998 Jan; 4(1):59-66. PubMed ID: 10183199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using economic threshold analysis to determine the intensity of HIV prevention services for HIV-seropositive persons.
    Holtgrave DR
    AIDS; 2005 Nov; 19(17):2025-9. PubMed ID: 16260910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
    Phillips KA; Hotlgrave DR
    Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the costs of preventive interventions.
    Foster EM; Porter MM; Ayers TS; Kaplan DL; Sandler I
    Eval Rev; 2007 Jun; 31(3):261-86. PubMed ID: 17478629
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.